Crescent Biopharma (C68) Q2 2026 Earnings Report
DE:C68 Q2 2026 EPS Results
- Actual EPS
- -EUR 0.63
- Consensus EPS
- -EUR 0.63
- Beat/Miss
- Missed by -EUR 0.00
- One Year Ago EPS
- -EUR 4.22
DE:C68 Q2 2026 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 305.91K
- Beat/Miss
- Missed by -EUR 305.91K
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 07/30/2026
- Time
- Before Open
- Conference Call
- Thursday, July 30, 2026
DE:C68 Upcoming Earnings
Crescent Biopharma's next earnings date is estimated for November 5, 2026, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:C68 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 05, 2026 | 2026 (Q3) | -0.58- | -1.09 | ― | ― |
| Jul 30, 2026 | 2026 (Q2) | -0.63-0.63 | -4.22 | 84.99% (+3.59) | |
| Apr 29, 2026 | 2026 (Q1) | -0.75-0.60 | -15.27 | 96.07% (+14.67) | |
| Feb 26, 2026 | 2025 (Q4) | -2.12-3.44 | -6.86 | 49.88% (+3.42) | |
| Nov 06, 2025 | 2025 (Q3) | -1.68-1.09 | -308.8 | 99.65% (+307.71) | |
| Jul 31, 2025 | 2025 (Q2) | -1.43-4.22 | -13.42 | 68.51% (+9.19) | |
| May 01, 2025 | 2025 (Q1) | -0.04-0.04 | -0.15 | 70.59% (+0.10) | |
| Feb 27, 2025 | 2024 (Q4) | -0.07-0.10 | -0.12 | 20.00% (+0.02) | |
| Nov 07, 2024 | 2024 (Q3) | -0.09-0.13 | -0.12 | -8.57% (-0.01) | |
| Aug 01, 2024 | 2024 (Q2) | -0.15-0.14 | -0.11 | -26.92% (-0.03) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed